Home
Science & Medicine
Diagnostic Oncology
Evolving Standards of Care
FDA Corner
Global Initiatives
Immunotherapy
Lung Cancer Screening
NCI Corner
Pathology
Prevention and Tobacco Control
Radiation Oncology
Supportive Care
Targeted Therapy
Advocacy & Survivorship
Thought-Leader Perspective
Allied Health
Meetings
Highlights
Preview
News
Breaking News Briefs
In Memoriam
People
Search
IASLC.org
IASLC Lung Cancer News
Home
Science & Medicine
Diagnostic Oncology
Evolving Standards of Care
FDA Corner
Global Initiatives
Immunotherapy
Lung Cancer Screening
NCI Corner
Pathology
Prevention and Tobacco Control
Radiation Oncology
Supportive Care
Targeted Therapy
Advocacy & Survivorship
Thought-Leader Perspective
Allied Health
Meetings
Highlights
Preview
News
Breaking News Briefs
In Memoriam
People
Home
Authors
Posts by lungcanc
lungcanc
526 POSTS
0 COMMENTS
Luis E. Raez, MD
lungcanc
2019 IASLC World Conference on Lung Cancer Updates
lungcanc
GLCC and IASLC Form Partnership to Explore Progress in Lung Cancer...
lungcanc
Consolidating Gains with Chemotherapy in SCLC Maintenance Trials: A Discussion with...
lungcanc
Ireland’s Complex Healthcare System and Its Relation to Innovative Ways for...
lungcanc
Tackling TKI-Refractory Disease in Patients with Oncogenic Drivers: An Interview with...
lungcanc
Making Headway with Lorlatinib
lungcanc
Clinical Utility of Plasma Next-Generation Sequencing in Advanced NSCLC: Are We...
lungcanc
Korean Lung Cancer Screening Project (K-LUCAS) Led to Launch of New...
lungcanc
Letter to the Editor: Previously Excluded Patients with Autoimmune Disorders, HIV,...
lungcanc
1
...
13
14
15
...
53
Page 14 of 53
Meeting News
Leora Horn, MD – IASLC Virtual Presidential Symposium Presentation
Paul Baas, MD – IASLC Virtual Presidential Symposium Presentation
TRACERx Data Show That Tracking MRD With ctDNA Heralds Disease Relapse
cfDNA Analysis Suggests EML4-ALK Variant Does Not Influence Response to Lorlatinib
Load more
Edit with Live CSS
